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1. INTHODUCTION 
The neurotransmitter dopamine regulates the activity 
of a number of vertebrate neural and endocrine cells. 
It is thought that disturbances of dopamine concentra- 
tions in the brain cause several neurological diseases 
[1,2]. Dopamine signalling is transduced by 2 phar- 
macologically different dopamine receptors, the DI 
receptor and the Da receptor [3,4]. Recent cloning of a 
rat Dz dopamine receptor cDNA showed that this 
receptor belongs to the family of G-protein-coupled 
receptors [5]. The structures of the members of this 
family are characterized by the presence of a core of 
seven membrane-spanning domains which display 
significant homology between the family members [6]. 
Further characterization of DZ receptor cDNAs and 
polymerase chain reaction (PCR) analysis of DZ recep- 
tor expression revealed in human, bovine and rat the 
presence of a 2nd, larger form of the D2 receptor 
[T- 123, This large form differs from the first-cloned rat 
DZ receptor by an additional stretch of 29 amino acid 
residues located in the predicted 3rd cytoplasmic loop 
between transmembrane domains V and VI. The occur- 
rence of the 2 molecular forms of the DZ receptor is the 
result of an alternative splicing event, the functional 
significance of which is not clear. 
In amphibians the dopamine receptor is likely to be 
involved in the regulation of the melanotrope cells of 
the intermediate pituitary gland during background 
adaptation of the animal 1131. Mclanotrope cells of 
animals on a black background release a.melanocytc- 
stimulating hormone ((r-MSH) which stimulates disper- 
sion of pigment granules in skin melanophores [ 141. In 
the amphibian Xenopus luevis dopaminergic neurons 
originating from hypothalamic nuclei innervate the 
melanotrope cells [15,16J and, in animais on a white 
background, dopamine receptor activation leads to an 
inhibition of the biosynthetic and secretory activity of 
the melanotropc ells [17]. This results in an inhibition 
of (U-WISH release and thus in a bleaching of the 
animal. Specific D2 dopamine receptor agonists and an- 
tagonists have been used to characterize the dopamine 
receptor present on the membrane of the Xevropus 
melanotrope cells as a Dz-type of dopamine receptor 
which appears to be pharmacologically somewhat dif- 
ferent from the mammalian Dz receptor [ I31. The ques- 
tion arises whether the observed pharmacological 
differences are due to differences between the struc- 
tures of the Xenopus and mammalian Dz receptors. As 
a first step towards a resolution of this question, we us- 
ed a rat Dz dopamine receptor cDNA as a probe to 
isolate a cDNA clone encoding a Xenopus D2 
dopamine receptor. 
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2. MATERIALS AND METHODS 
To determine the hybridization conditions for library screening, 
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3. RESULTS AND DISCUSSION 
3 .l . The Xenopus 02 dopcttttine receptor 
A Xenopm brain cDNA library (1,5x 106 clones) 
was screened under low-stringency hybridization condi- 
tions using as a probe a 1.3 kb DNA fragment of rat DZ 
dopamine receptor cDNA clone pGRB-2 [5] which 
covers the nearly complete protein-coding region. This 
screening gave a total of 140 hybridization-positive 
signals, 10 of which represented strong positives. Upon 
rescreening with a 0.55 kb DNA fragment of pCiRB-2 
encoding the amino.tcrminal region of the rat DZ recep- 
tor, Xenopus brain cDNA clone pHRlXD2 (length of 
insert 2.1 kb) was selected for further analysis. Fig. 1 
shows the nucleotide sequence of pHRlXD2 cDNA 
which comprises 2068 bp. The longest open-reading 
frame (ORF) codes for a 442 amino acid protein 
(relative molecular mass M, 49680). This protein lacks 
a signal sequence and it contains 7 putative transmem- 
brane regions, a structural characteristic of G-protcin- 
coupled receptors [20]. From the high degree of identity 
between the amino acid sequence of the pHRlXD2 pro- 
tein and mammalian DZ dopamine receptor structures 
(Fig. 2) we conclude that pHRlXD2 cDNA encodes a 
Xenopus DZ dopamine receptor. This receptor cor- 
responds to the large form of the DZ dopamine receptor 
relative to the first-cloned rat D2 receptor. Interesting- 
ly, the Xenopus D2 receptor contains an additional 33 
amino acid sequence in the predicted intracellular do- 
main between transmembrane regions V and VI, 
whereas in the large form of the mammalian D:! recep- 
tor only an additional 29 amino acids are present in this 
region. The occurrence of the 2 molecular forms of the 
mammalian Da receptors appears to be the result of 
alternative splicing, involving an exon of 87 bp in the 
human, bovine and rat genes [7-123. In the Xenopus 
Dz receptor gene a somewhat larger exon of 99 bp is ex- 
pected to be involved. The fact that the region in the 
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%enctprrs RTJ rcceptar mRNA which cowexpands to thr: 
mammalian splice lnitc (QTWATTCTT, nuckotldes 
127%1287, Fig. 1) does nat sanfwm very well IS the. 
CQWWiZW rcqucncc far splice donor sires 
($KMZiT&UYlJ [al] might explain why in dr”ttrruprr~ 
the cxsn-inrran splicing cvenr rlid not weur after 
87 bp in this cxon. The corresponding splise region 
within the mammalian I& reccpttlr gene sequence 
(~TWGTAAGT) [‘I==$] conforms well to the eonsensur 
seqlrCncc. 
An unusual fczlt.ure uf the Xcrroj>lc~ Da receptor 
mRNA concerns the presence of an cxccpfionally long 
S’-noncodiny segment with 4 small ORFs, 3 of which 
arc in-frame with the BZ receptor-coding sequence 
(Fig, 1). The existence of these small ORFs means that 
the ORF encoding the Xenoprrs Da receptor protein 
starts at the 5th AUG codon. This is remarkable 
because translation of most eukaryotic mRNAs starts 
at the 1st AUG [22]. Whether the small ORFs are 
translated and, if so, what the functional role of the 
resulting peptides might be, remains to be established. 
It is of interest that the region which contains the most- 
downstream small ORF (TATGGCTTG&%GACiCT, 
nucleotides 456-471, Fig. 1) is identical between 
Xenop~ts, human and rat Dz receptor mRNAs, whereas 
the remainder of the 5’-untranslated region is highly 
divergent between the 3 species (this region is not 
reported for the bovine receptor). Unfortunately, a full 
comparison between the Xenopus 5 ’ -untranslated seg- 
ment and the corresponding mammalian regions is not 
possible since all previously reported DZ receptor 
cDNAs contain only relatively short 5 ’ -noncoding 
regions. Only 5-10% of vertebrate mRNAs have 
upstream AUG codons; this set of mRNAs is apparent- 
ly nonrandom in that many mRNAs encoded by pro- 
tooncogenes, growth-control genes and receptor genes 
belong to it [23--251. The role of long 5’.untranslated 
sequences with upstream AUG codons has not been 
clearly established in higher eukaryotes. In yeast, 
however, upstream AUGs repress the efficiency of 
translation initiation of the long downstream ORF, and 
thus a function for these sequences at the level of 
regulation of translation has been suggested [26,27]. 
The presence of the small upstream ORFs in the 
Xenopus D2 receptor mRNA would seem to necessitate 
that the process of translation reinitiation must occur 
for DZ receptor translation. The AUG codon of the 3rd 
small ORF lies in an excellent context for initiating 
translation (ACCAUGG, nucleotides 355-361, Fig. 1; 
consensus for strong eukaryotic translation initiation 
sequence is ;NNAUGG, whereby N is mostly a C) [22]. 
The 3rd AUG will thus very likely function as a 
ribosome start site. Moreover, the AUG start codon of 
the D2 receptor is in a rather unfavorable context 
(UKJCAUGG). Therefore, the only reason why 
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Fig. 1. Nucleotide sequence and deduced amino acid sequence of brain cDNA encoding a Xettopus D2 dopamine receptor. The 4 small open- 
reading frames in the 5’-untranslated mRNA region are underlined. Predicted transmembrane domains are overlined. The 99-bp/33-amino acid 
insertion sequence is boxed; the small isoform of the mammalian receptor lacks this sequence [7-121. Asterisks indicate potential N-linked 
glycosylation sites [33]. 
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ing [23], and it has been liLQ$ClWl tlral in prataan- 
eoyenc expressian upstream AUG codona may be lost 
during the ehramasamal rcarrnngcmcnts that wectx~~- 
pany nccivatisn of sxrw sncoyencr [SSr]. tn this rcxpccr 
it is intererring to note that R S’-noncoding splice 
variant of the human DZ receptor mRNA has recently 
been described [28]. Whether this finding implies that 
a critical regulatory step in Da receptor gene expression 
eoncerna the processing of stable, untranslatable prc- 
mRNA to ftmccional Da receptor mRNA or, elrer- 
natively, whcrher the cranslstiannl mnchincry is forced 
to de,\1 with the upstream GUG triplets, has to await 
further experimentation. 
The overall degree of amino acid scqucncc identity 
between the Xertoprts and (the large forms of the) 
human, bovine and rat Bt receptors is 7590, 750/o and 
74%, respectively, while on the nuclcoride scqucncc 
level in the protein-coding regions the identity is 6770, 
68% and 65%, respectively. The evolutionary span bet- 
ween these species is about 350 million years. No 
significant nucleotide sequence identity was found bet- 
ween the S’-untranslated nor the 3’.untranslated 
regions of the DZ receptor mRNAs of the 4 species, ex- 
cept for the short sequence in the 5’-untranslated 
region (see above), All predicted cransmembranc do- 
mains are highly conserved as are the regions between 
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domains I and I1 i(firrt intrnrcllrrlnr loop), II and Itf 
(firrt wtracellulttr Isop), Lll and IV (4lccond In- 
tracellular laap), VI and VII (third esttraccllular loop), 
and rhc ~~rb~x~t~rrnifl~l portilrn 00’ the: receptors, In 
cortfrw, the rrrnino-terminal region aa well 0% the 2ncl 
exrracclltrlar loop between domains IV und V, nnd most 
of the 3rd eytoplasmic loop between domains V and VI 
display a low degree of scquencr identity, Despite the 
low homology between the amino-terminal portions of 
chc 131 reccp~ors, the 3 potential sites for N-linked 
glycosylation located in this region are present in all 4 
xpecics. In the 2nd cxtraccllular loep and the 3rd in- 
tracellular loop, however, not all potential glycoayln- 
rion sites are conserved (Fig. 2). Interestingly, the most 
conscrvrd regions within the 3rd cytoplaxmic loop, 
namely those flanking trawnembranc domains V and 
VI, are believed to be involved in binding of the! rcccp- 
car to a G-pratein, possibly in conjunction with the 
well-conserved 2nd cytoplarmic loop [29]. Except for 
the amino- and earboxy-terminal ends, most of the 
third cytoplasmic loop, including the region containing 
the site of deletion/insertion of the 33 amino acid 
residues (29 rcsiducs in the mammalian receptors), con- 
stitutss one of the least conserved regions of the Dz 
receptor, This low degree of identity is pertinent to the 
question of whether the alternative splicing event is of 
functional significance (cf. [8]). Aspartatcs 80, 108 and 
114 (numbering for mammalian receptors) and the 
regions surrounding thcsc residues in transmcmbrane 
R SRGV---AVDAHWDK THPEDVKLCS FVKSNOSF ADKKKVILV;EA KHPEDMEt4tZM SSTSPPPK KHKSASP 
$jAFRAHLRAp&ki&mj ?j 0 E rj$iiz+~RYSPIp[ IN SNGSF VNRRRV----EAARRAQELEPlEN 
RSSRRFRANLKTF K-------------------,.-------------DA RRAQELEMEM SSTSPPER RYSPIPP 
Fig. 2. Alignment of the amino acid sequences of Xenopus, human and (the small isoform of the) rat Dz dopamine receptors. The one-letter amino 
acid notation is used, Claps (-) have been introduced to achieve maximum identity. Residues identical among the receptor structures of the three 
species are boxed as are the residues identical between the Xenopus and human receptors in the insertion sequence. Predicted transmembrane 
domains I to VII are overlined. Asterisks indicate potential N-linked glycosylation sites [33]. The dot indicates a potential CAMP-dependent 
protein kinase phosphorylation site [34]. Triangles denote the ends of the insertion sequence of the mammalian receptor. 
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dwnt~lnr II nnci III rtlrc identical arnangl the 4 spceieo, 
which ir In line with their prcqxxed impartant rdc in 
bindirq at+ the catlank nnrine IQ the reccprerr [XI]. 
Similwly, ncverwl xrinc and chreanina reriidurs in the 
3rd cytapleamic 19ap AFQ well csnrcrucd; these residuas 
cauld SEWC at ?eitcs ~BF phsqArarylatian and they might 
rhcrcf’cn-e be involvccl in the rcgulatian sf Da reccpl&- 
Functioning [3 I]. The con!wvation af Al cystrinr! 
rcsidws might reflect the imparrnnr relc for these 
amino acids in establishinp the tczrtinry structure of the 
Da receptor [32]. On the basis of our comparative 
analyslis we conclude that the observed patwnr of con- 
scrwion and divergence of’ regions within the I& 
rcccpror prsrein will help to delineate the portions aF 
the rcccptw molcculc which we important for proper 
receptor functioning. 
In Xenoprts it appclsrs thnt, through DZ receptor triy- 
gering, dopnmine regulntet the activity of the 
mclnnotrope cells af the intermediate picuirary gland 
during the process of background adaptation of the 
animal [13]. Preliminary results of PCi% analysis using 
primers directed against portions oi’ the 3rd and 6th 
cransmembrane domains of the Xerropus Da receptor 
have revealed that, as in mammals [5,8], the D: recep- 
tor is expressed in the Xmopus intermediate pituitary. 
Structure-function studies arc in progress to examine 
the relationship bctwcen the structural differences 
described here and the previously reported [13] dif- 
fercnt pharmacological characrcriatics af the Xenopus 
and mammalian D2 receptors. 
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